On March 26, AK MEDICAL (01789) spent HKD 7.1879 million to repurchase 1.194 million shares.
Aikang Medical (01789) announced that on March 26, 2026, the company spent 7.1879 million Hong Kong dollars to repurchase 1.194 million shares, at a repurchase price of 6.02 Hong Kong dollars per share.
AK MEDICAL (01789) announced on March 26, 2026 that the company will spend 7.1879 million Hong Kong dollars to repurchase 1.194 million shares at a repurchase price of 6.02 Hong Kong dollars per share.
Related Articles
AIA (01299) grants 2,174,400 stock options.
KEYMED BIO-B(02162) released its annual performance with a net loss of 523 million yuan for shareholders, a year-on-year increase of 1.44%.
SOUTHGOBI (01878) issues profit warning, expecting a net loss of approximately 152 million to 186 million US dollars, a year-on-year change from profit to loss.
AIA (01299) grants 2,174,400 stock options.
KEYMED BIO-B(02162) released its annual performance with a net loss of 523 million yuan for shareholders, a year-on-year increase of 1.44%.
SOUTHGOBI (01878) issues profit warning, expecting a net loss of approximately 152 million to 186 million US dollars, a year-on-year change from profit to loss.
RECOMMEND
Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026
Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026
Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026
